NCT02250781View on ClinicalTrials.gov

Oral ONC201 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 12, 2015

Primary Completion Date

October 18, 2018

Study Completion Date

October 25, 2018

Conditions
Solid Tumors
Interventions
DRUG

Oral ONC201

Given PO

Trial Locations (1)

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Rutgers Cancer Institute of New Jersey

OTHER

lead

Rutgers, The State University of New Jersey

OTHER

NCT02250781 - Oral ONC201 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter